Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.19% | -26.39% | 10.99% | -2.80% | -39.69% |
| Total Depreciation and Amortization | -6.86% | 11.69% | -41.44% | 126.47% | -13.82% |
| Total Amortization of Deferred Charges | -2.59% | 0.39% | -1.53% | 0.90% | -1.40% |
| Total Other Non-Cash Items | 41.58% | 17.50% | 4.47% | -26.90% | 390.34% |
| Change in Net Operating Assets | -154.83% | 242.19% | -226.23% | -1,468.49% | 105.56% |
| Cash from Operations | -18.84% | 35.08% | -6.66% | -16.35% | -6.50% |
| Capital Expenditure | 50.25% | 84.43% | -579.79% | 54.81% | -152.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.15% | -50.70% | 65.38% | 25.00% | -51.63% |
| Cash from Investing | 35.48% | 91.25% | -1,732.76% | 81.41% | -724.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 47.66% | 75.51% | 47.98% | -813.04% | -2.22% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | 62.56% | 64.62% | -- | -- |
| Cash from Financing | 927.69% | 245.51% | -101.24% | 57,019.12% | -1.49% |
| Foreign Exchange rate Adjustments | 208.57% | -166.88% | 36.52% | 169.28% | -184.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.40% | 44.48% | -156.91% | 328.94% | -13.85% |
